Although Suzuki et al. [32] observed no SP-A staining in other primary lung carcinomas or adenocarcinomas of other organs, they suggested napsin A (an aspartic protease, involved in pro-SP-B processing) to be a better disease marker. Here, SFTPA1 is linked to lung carcinoma.